Ukraine covid-19 vaccine Coronavirus Ukraine

Study: J&J COVID-19 vaccine significantly less effective against delta variant

Reading now: 303
www.fox29.com

study published on July 19 on the medical journal website BioRxiv found that the single-dose Johnson & Johnson vaccine was significantly less effective against the highly transmissible delta and lambda variants compared with two-dose vaccines from Pfizer and Moderna.

Study authors found that while the two-dose vaccines were 94-95% effective in preventing COVID-19, the J&J vaccine had only 66.9% efficacy "in preventing moderate to severe disease." The study compared the efficacy and drop-off rate of antibody protection from all three vaccines and found that neutralization of the delta and lambda variants decreased with the J&J vaccine.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA